Targeting tumor-resident mast cells for effective anti-melanoma immune responses

Immune checkpoint blockade has revolutionized cancer treatment. Patients developing immune mediated adverse events, such as colitis, appear to particularly benefit from immune checkpoint inhibition. Yet, the contributing mechanisms are largely unknown. We identified a systemic LPS signature in melan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Kaesler, Susanne, Wölbing, Florian, Kempf, Wolfgang Eberhard, Skabytska, Yuliya, Köberle, Martin, Volz, Thomas, Sinnberg, Tobias, Amaral, Teresa, Möckel, Sigrid, Yazdi, Amir, Metzler, Gisela, Schaller, Martin, Hartmann, Karin, Weide, Benjamin, Garbe, Claus, Rammensee, Hans-Georg, Röcken, Martin, Biedermann, Tilo
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795496/
https://ncbi.nlm.nih.gov/pubmed/31578309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.125057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados